Daniel Sahm

Publishing 2009

Is this you? Claim this profile
1
Article
33
Reads on Journament
0
Co-authors
1
Journal

This page collects the articles indexed under the name Daniel Sahm. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.

Publications 1

  1. In Vitro Activity of Doripenem
    clinical infectious diseases 2009 33 reads

Possible papers by Daniel Sahm 7

Published under a similar spelling of the name. Beside each paper is the evidence that it may be the same person, strongest first; "Same name only" means there is nothing else to go on.

  1. Stable Antimicrobial Susceptibility Rates for Clinical Isolates of Pseudomonas aeruginosa from the 2001–2003 Tracking Resistance in the United States Today Surveillance Studies
    as Daniel F. Sahm clinical infectious diseases 2005
    Same journal
  2. Factors Associated with Relative Rates of Antimicrobial Resistance among Streptococcus pneumoniae in the United States: Results from the TRUST Surveillance Program (1998–2002)
    as Daniel F. Sahm clinical infectious diseases 2003
    Same journal
  3. Susceptibility of Antimicrobial-Resistant Urinary Escherichia coli Isolates to Fluoroquinolones and Nitrofurantoin
    as Daniel F. Sahm clinical infectious diseases 2003
    Same journal
  4. Reply
    as Daniel F. Sahm clinical infectious diseases 2002
    Same journal
  5. Regional Trends in Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST Surveillance Program, 1999–2000
    as Daniel F. Sahm clinical infectious diseases 2002
    Same journal
  6. Long–term trends in ceftolozane–tazobactam susceptibility among gram–negative pathogens in the United States: a nine–year SMART analysis (2016–2024)
    as Daniel F. Sahm JAC-Antimicrobial Resistance 2026
    Same name only
  7. in vitro activity of iclaprim against methicillin-resistant staphylococcus aureus nonsusceptible to daptomycin, linezolid, or vancomycin: a pilot study
    as Daniel F. Sahm zdravstveno varstvo 2017
    Same name only

Under these spellings

Same person? Claim this profile, then add these papers one by one or combine a whole spelling.

Is this you?

Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.

Also published as

Tick the other spellings that are you. Leave the rest.

An admin reviews every claim. Your account's name, email address and affiliation are shown to them too.

You need an account to claim. No password: we email you a sign-in link, and your claim is sent as soon as you are back.

Publishes in